COR | LOE | RECOMMENDATION |
---|---|---|
1 | B-NR | 1. Patients with AF, regardless of sex1 and gender diversity, race and ethnicity,2 or adverse social determinants of health (SDOH),3,4,* should be equitably offered guideline-directed stroke risk reduction therapies as well as rate or rhythm control strategies and LRFM as indicated to improve quality of life (QOL) and prevent adverse outcomes. |